Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy

Overexpression of protein tyrosine phosphatase 1B (PTP1B) induces insulin resistance in various basic and clinical research. In our previous work, a synthetic oleanolic acid (OA) derivative C10a with PTP1B inhibitory activity has been reported. However, C10a has some pharmacological defects and cyto...

Full description

Bibliographic Details
Main Authors: Lingling Yang, Feng Chen, Cheng Gao, Jiabao Chen, Junyan Li, Siyan Liu, Yuanyuan Zhang, Zhouyu Wang, Shan Qian
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2019.1690481
id doaj-7b7c47eabaf2438aae0c8d531db1a2dd
record_format Article
spelling doaj-7b7c47eabaf2438aae0c8d531db1a2dd2021-07-15T13:10:31ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742020-01-0135115216410.1080/14756366.2019.16904811690481Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacyLingling Yang0Feng Chen1Cheng Gao2Jiabao Chen3Junyan Li4Siyan Liu5Yuanyuan Zhang6Zhouyu Wang7Shan Qian8Department of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityDepartment of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityDepartment of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityDepartment of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityDepartment of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityDepartment of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityDepartment of Chemistry, College of Science, Xihua UniversityDepartment of Chemistry, College of Science, Xihua UniversityDepartment of Pharmaceutical Engineering, College of Food and Bioengineering, Xihua UniversityOverexpression of protein tyrosine phosphatase 1B (PTP1B) induces insulin resistance in various basic and clinical research. In our previous work, a synthetic oleanolic acid (OA) derivative C10a with PTP1B inhibitory activity has been reported. However, C10a has some pharmacological defects and cytotoxicity. Herein, a structure-based drug design approach was used based on the structure of C10a to elaborate the smaller tricyclic core. A series of tricyclic derivatives were synthesised and the compounds 15, 28 and 34 exhibited the most PTP1B enzymatic inhibitory potency. In the insulin-resistant human hepatoma HepG2 cells, compound 25 with the moderate PTP1B inhibition and preferable pharmaceutical properties can significantly increase insulin-stimulated glucose uptake and showed the insulin resistance ameliorating effect. Moreover, 25 showed the improved in vivo antihyperglycaemic potential in the nicotinamide–streptozotocin-induced T2D. Our study demonstrated that these tricyclic derivatives with improved molecular architectures and antihyperglycaemic activity could be developed in the treatment of T2D.http://dx.doi.org/10.1080/14756366.2019.1690481protein tyrosine phosphatase 1boleanolic acidinsulin-resistantantihyperglycaemic effecttype 2 diabetes
collection DOAJ
language English
format Article
sources DOAJ
author Lingling Yang
Feng Chen
Cheng Gao
Jiabao Chen
Junyan Li
Siyan Liu
Yuanyuan Zhang
Zhouyu Wang
Shan Qian
spellingShingle Lingling Yang
Feng Chen
Cheng Gao
Jiabao Chen
Junyan Li
Siyan Liu
Yuanyuan Zhang
Zhouyu Wang
Shan Qian
Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
Journal of Enzyme Inhibition and Medicinal Chemistry
protein tyrosine phosphatase 1b
oleanolic acid
insulin-resistant
antihyperglycaemic effect
type 2 diabetes
author_facet Lingling Yang
Feng Chen
Cheng Gao
Jiabao Chen
Junyan Li
Siyan Liu
Yuanyuan Zhang
Zhouyu Wang
Shan Qian
author_sort Lingling Yang
title Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
title_short Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
title_full Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
title_fullStr Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
title_full_unstemmed Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
title_sort design and synthesis of tricyclic terpenoid derivatives as novel ptp1b inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
publisher Taylor & Francis Group
series Journal of Enzyme Inhibition and Medicinal Chemistry
issn 1475-6366
1475-6374
publishDate 2020-01-01
description Overexpression of protein tyrosine phosphatase 1B (PTP1B) induces insulin resistance in various basic and clinical research. In our previous work, a synthetic oleanolic acid (OA) derivative C10a with PTP1B inhibitory activity has been reported. However, C10a has some pharmacological defects and cytotoxicity. Herein, a structure-based drug design approach was used based on the structure of C10a to elaborate the smaller tricyclic core. A series of tricyclic derivatives were synthesised and the compounds 15, 28 and 34 exhibited the most PTP1B enzymatic inhibitory potency. In the insulin-resistant human hepatoma HepG2 cells, compound 25 with the moderate PTP1B inhibition and preferable pharmaceutical properties can significantly increase insulin-stimulated glucose uptake and showed the insulin resistance ameliorating effect. Moreover, 25 showed the improved in vivo antihyperglycaemic potential in the nicotinamide–streptozotocin-induced T2D. Our study demonstrated that these tricyclic derivatives with improved molecular architectures and antihyperglycaemic activity could be developed in the treatment of T2D.
topic protein tyrosine phosphatase 1b
oleanolic acid
insulin-resistant
antihyperglycaemic effect
type 2 diabetes
url http://dx.doi.org/10.1080/14756366.2019.1690481
work_keys_str_mv AT linglingyang designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT fengchen designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT chenggao designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT jiabaochen designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT junyanli designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT siyanliu designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT yuanyuanzhang designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT zhouyuwang designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
AT shanqian designandsynthesisoftricyclicterpenoidderivativesasnovelptp1binhibitorswithimprovedpharmacologicalpropertyandinvivoantihyperglycaemicefficacy
_version_ 1721300937985753088